Physician profile
Mark D Berner
NPI 1316061518
$1,922.51
in general payments reported to CMS, 2019-2025
10 companies · $336 in 2025
The $336 reported for 2025 was more than what 75% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $943 · 2021: $347 · 2022: $22.71 · 2023: $29.31 · 2024: $116 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $925.00 | 2020 | |
| Boston Scientific Corporation | $315.66 | 2020-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Obsidio, General - Embolics |
| Penumbra, INC. | $272.48 | 2021-2025 | Penumbra Coil 400 |
| Sirtex Medical INC | $144.66 | 2025 | Sir-Spheres Microspheres |
| Astrazeneca Pharmaceuticals LP | $116.76 | 2019 | |
| Medtronic, INC. | $43.79 | 2021-2024 | Abre |
| Angiodynamics, INC. | $40.66 | 2021-2022 | |
| Inari Medical, INC. | $35.01 | 2021 | |
| Bard Peripheral Vascular, INC. | $16.71 | 2024 | Denali Vena Cava Filter |
| Ekos Corporation | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Berner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.